SESusan M. Engelhardt

Susan M. Engelhardt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Susan M. Engelhardt has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • A. Cernich

    Department of Veterans Affairs Medical Center , Baltimore , Maryland , USA

    2 shared publications
  • B. Kaup

    Department of Veterans Affairs Medical Center , Baltimore , Maryland , USA ; Department of Psychiatry , University of Maryland, School of Medicine , Baltimore , Maryland , USA

    2 shared publications
  • C. D. Dorsey

    Department of Medicine , University of Maryland, School of Medicine , Baltimore , Maryland , USA ; Department of Veterans Affairs Medical Center , Baltimore , Maryland , USA

    2 shared publications
  • D. Hoover

    Department of Anatomy and Neurobiology , University of Maryland, School of Medicine , Baltimore , Maryland , USA

    2 shared publications
  • K. S. Squibb

    Department of Medicine , University of Maryland, School of Medicine , Baltimore , Maryland , USA ; Department of Veterans Affairs Medical Center , Baltimore , Maryland , USA

    2 shared publications
  • L. Brown

    Department of Veterans Affairs Medical Center , Baltimore , Maryland , USA ; Department of Pathology , University of Maryland, School of Medicine , Baltimore , Maryland , USA

    2 shared publications

Latest Publications

  • Longitudinal Health Surveillance in a Cohort of Gulf War Veterans 18 Years After First Exposure to Depleted Uranium

    by M. A. McDiarmid, S. M. Engelhardt, C. D. Dorsey, M. Oliver, P. Gucer, J. M. Gaitens, R. Kane, A. Cernich, B. Kaup, D. Hoover, et al.

    As part of a longitudinal surveillance program, 35 members of a larger dynamic cohort of 79 Gulf War I veterans exposed to depleted uranium (DU) during combat underwent clinical evaluation at the Baltimore Veterans Administration Medical Center. Health outcomes and biomonitoring results were obtained to assess effects of DU exposure and determine the need for additional medical intervention. Clinical evaluation included medical and exposure histories, physical examination, and laboratory studies including biomarkers of uranium (U) exposure. Urine collections were obtained for U analysis and to measure renal function parameters. Other laboratory measures included basic hematology and chemistry parameters, blood and plasma U concentrations, and markers of bone metabolism. Urine U (uU) excretion remained above normal in participants with embedded DU fragments, with urine U concentrations ranging from 0.006 to 1.88 μg U/g creatinine. Biomarkers of renal effects showed no apparent evidence of renal functional changes or cellular toxicity related to U body burden. No marked differences in markers of bone formation or bone resorption were observed; however, a statistically significant decrease in levels of serum intact parathyroid hormone and significant increases in urinary calcium and sodium excretion were seen in the high versus the low uU groups. Eighteen years after first exposure, members of this cohort with DU fragments continue to excrete elevated concentrations of uU. No significant evidence of clinically important changes was observed in kidney or bone, the two principal target organs of U. Continued surveillance is prudent, however, due to the ongoing mobilization of uranium from fragment depots.


  • Surveillance Results of Depleted Uranium–Exposed Gulf War I Veterans: Sixteen Years of Follow-Up

    by M. A. McDiarmid, S. M. Engelhardt, C. D. Dorsey, M. Oliver, P. Gucer, P. D. Wilson, R. Kane, A. Cernich, B. Kaup, L. Anderson, et al.

    As part of a longitudinal surveillance program, 35 members of a larger cohort of 77 Gulf War I veterans who were victims of depleted uranium (DU) “friendly fire” during combat underwent a 3-day clinical assessment at the Baltimore Veterans Administration Medical Center (VAMC). The assessment included a detailed medical history, exposure history, physical examination, and laboratory studies. Spot and 24-h urine collections were obtained for renal function parameters and for urine uranium (U) measures. Blood U measures were also performed. Urine U excretion was significantly associated with DU retained shrapnel burden (8.821 μg U/g creatinine [creat.] vs. 0.005 μg U/g creat., p = .04). Blood as a U sampling matrix revealed satisfactory results for measures of total U with a high correlation with urine U results (r = .84) when urine U concentrations were ≥0.1 μg/g creatinine. However, isotopic results in blood detected DU in only half of the subcohort who had isotopic signatures for DU detectable in urine. After stratifying the cohort based on urine U concentration, the high-U group showed a trend toward higher concentrations of urine β2 microglobulin compared to the low-U group (81.7 v. 69.0 μg/g creat.; p = .11 respectively) and retinol binding protein (48.1 vs. 31.0 μg/g creat.; p = .07 respectively). Bone metabolism parameters showed only subtle differences between groups. Sixteen years after first exposure, this cohort continues to excrete elevated concentrations of urine U as a function of DU shrapnel burden. Although subtle trends emerge in renal proximal tubular function and bone formation, the cohort exhibits few clinically significant U-related health effects.


  • Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium

    by Melissa A. McDiarmid, Susan M. Engelhardt, Marc Oliver, Patricia Gucer, P. David Wilson, Robert Kane, Michael Kabat, Bruce Kaup, Larry Anderson, Dennis Hoover, et al.

    Objective: To relate medical surveillance outcomes to uranium biomonitoring results in a group of depleted uranium (DU)-exposed, Gulf War I veterans. Methods: Thirty-two veterans of Gulf War I who were victims of ‘friendly fire’ involving DU weapons, in whom exposure assessment can accurately be measured, had urine uranium concentrations determined using ICP-MS technology. Clinical laboratory parameters were measured and related to urine uranium concentrations. Data were examined by stratifying the cohort into a low U group, Results: Over a decade after first exposure, soldiers possessing embedded DU fragments continue to excrete elevated concentrations of uranium in urine. No clinically significant uranium related health effects were observed in blood count, blood chemistries including renal markers, neuropsychological measures, and semen quality or genotoxicity measures. Markers of early changes in renal glomerular and tubular function were not statistically different between groups; however, genotoxicity measures continue to show subtle, mixed results. Conclusion: Persistent urine uranium elevations continue to be observed more than 12 years since first exposure. Despite this, renal and other clinical abnormalities were not observed, likely due to the ‘relatively’ low uranium burden in this cohort compared to historical uranium-exposed occupational groups. Continuing surveillance is indicated, however, due to the on-going nature of the exposure. These results are an important finding in light of the on-going controversy regarding health effects observed in soldiers of the Gulf War and other conflicts, whose uranium exposure assessment is unable to be accurately determined.